Atlas Trials

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject

Clinical trial NCT04041544 · UNKNOWN

Trial details

NCT number
NCT04041544
Sponsor
SinoMab BioScience Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Diseases
Start date
2019-08-27
Primary completion
2020-07-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.